The Retreatment of Carboplatin via High Dose Intraperitoneal Chemotherapy in Patients with a History of a Hypersensitivity Reaction Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Saturday, November 02, 2013

The Retreatment of Carboplatin via High Dose Intraperitoneal Chemotherapy in Patients with a History of a Hypersensitivity Reaction



abstract


"A hypersensitivity reaction (HSR) attributed to platinum-based chemotherapy is a relatively common occurrence. Hyperthermic intraperitoneal chemotherapy (HIPEC) potentially facilitates the safe retreatment of platinum therapy following this complication. We describe three ovarian cancer patients who were successfully retreated with carboplatin via HIPEC following an HSR."
 

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.